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Systemic  graft-versus-host  (GVH)  ~  disease  arising  in  F~  animals  injected  with 
thymus-derived (T) lymphocytes of  parental origin  is a complex phenomenon 
(1).  F~ animals express the transplantation  antigens of  both parents codomi- 
nantly and it is generally assumed that they are unable to reject  gral~ of 
immunocompetent parental lymphoid cells;  as a consequence, they are suscep- 
tible  to GVH  disease.  Normal adult  F~ animals are comparatively resistant  to 
GVH  disease,  the infusion  of  large  numbers of  parental  cells  being  required  to 
elicit  GVH  symptoms (2).  In contrast,  F~ hosts  first  given sublethal  whole body 
irradiation  are susceptible  to  much lower  dosages  of  parental  cells  (2-5).  There 
are several  possible  explanations that might be offered  to account for the 
relative  resistance  of  intact  FI animals to GVH  disease  compared to irradiated 
recipients.  It may reflect,  for example, the ability  of the host to develop an 
immune response against  receptors  present  on donor  parental  strain  T lympho- 
cyte subpopulations specific  for  host antigens (6).  For reasons of  self-tolerance 
these  receptors  are  considered  to  be  lacking  in  the  host  and  therefore  they  could 
be  immunogenic. 
Recent studies  (7)  supporting this  argument have demonstrated that a state 
of  specific  resistance  to local  GVH  reactions  can be induced in F1 rats  by prior 
inoculation  with  subclinical  doses  of  parental  strain  T cells.  After  immunization 
with lymphocytes from one parental strain (A),  A/B FI animals no longer 
display  the  expected  degree  of  lymph node enlargement  in  popliteal  lymph node 
assays when they are subsequently injected  with lymphocytes of the same 
parental strain.  This resistance  to local  GVH  reactions is specific  for the 
immunizing parental strain (A),  since  cells  from the other strain  parent (B) 
continue to cause enlarged nodes.  Furthermore, it  depends on the presence in 
the immunizing strain  A lymphocyte population  of  T cells  with competence for 
strain  B alloantigens;  lymphocytes depleted of  T cells,  or T cells  depeleted  of 
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specific alloreactivity to host alloantigen by negative selection procedures fail 
to induce specific local GVH resistance. 
The  present  studies  show  that  inoculation of F1  animals with subclinical 
dosages  of parental lymphocytes also induces a  state of specific resistance to 
systemic GVH disease.  This resistance affords a marked degree of protection 
against GHV mortality,  is radioinsensitive,  can be transferred adoptively to 
naive syngeneic F1 hosts,  is mediated by host T cells, and is directed against 
specific  anti-major  histocompatibility  complex  (MHC)  receptors  on  donor  T 
cells. 
Materials and Methods 
Rats.  Lewis (Ag-B1), BN (Ag-B3), and L/BN F~ hybrids were purchased from Microbiological 
Associates,  Walkersville,  Md.  L.B3  rats  were  obtained  as  a  gift from  Dr.  Charles  DeWitt, 
University of Utah. This congenic strain carries the B3 AgB-MHC haplotype of BN rats on the 
Lewis background.  DA (Ag-B4), August 28807 (Aug; Ag-B5), and the F~ hybrids L/DA and DA/ 
Aug were derived from our own colonies. 
F~  hybrid  B  rats  were  prepared  by  thymoctemy  at  6  wk  of age,  lethal  irradiation,  and 
reconstitution with small numbers of T-cell-deficient marrow cells (8). Lymphocyte populations 
from  these  rats  are  uureactive  in  mixed lymphocyte cultures  (MLC)  (9)  and  local  GVH  (9) 
reactions and do not respond to phytehemagglutinin (10). A control group of F~ rats was similarly 
treated except that they were sham thymectomized. 
Lymphocyte Populations.  Lymphocytes were obtained from the peripheral blood, lymph nodes 
and spleen,  as previously described  (11). The first 24 h  drainage of thoracic duct lymphocytes 
(TDL) was collected at 4°C into Hanks' phosphate-buffered saline supplemented with fetal calf 
serum (2% vol/vol, HPBS-FCS) and heparin (10 U/ml). Thoracic duct cannulations were performed 
as recently redeseribed by Ford and Hunt (12). 
Nylon wool purification of splenic lymphocytes utilized slight modifications of the procedure 
described by Julius et al. (13). Nylon wool was boiled in distilled water for 1 h before packing 1.2- 
g portions of wet wool into 20 cc syringe barrels to the 12 cc level. 300 x  10  e NH4Cl-treatod splenic 
lymphecytes, in a total vol of 3 ml medium (RPMI-1640, supplemented with FCS (10% vol/vol) and 
Hepes buffer (1 raM) Microbiological Associates followed by 3 ml of medium were added drop by 
drop to the column.  The  ~  column was then incubated for 1 h  at 37°C. Nonadherent cells were 
collected by the drop addition of 30 ml of RPMI-FCS. 
Negatively selected L T-cell populations, specifically depleted of alloreactivity to BN alloanti- 
gens, were prepared as described elsewhere (14). These TDL populations consist predominantly 
(> 95%) ofT cells and are unreactive to BN alloantigens in MLC (10), local GVH reactions (10, 
14), and, as demonstrated in Table VII, do not induce systemic GVH disease in irradiated L/BN 
rats. Their response to third party MHC alloantigens remains normal on a coil-for-cell basis. 
GVH Mortality Assays.  F~ rats to be tested for susceptibility to systemic GVH disease were 
given sublethal whole body irradiation (450 rads).  Parental cells were then injected immediately 
or on the day after irradiation. To eliminate cage effects, control animals expected to die, and 
experimental animals expected to live were mixed in the same cage. Animals succumbing to GVH 
disease usually died between 14 and 21 days; none lived longer than 30 days. Therefore, animals 
living longer than 60 days were scored as survivors. 
Antisera.  Rabbit  anti-rat  T-cell and  B-cell  sera  were prepared  and  tested  by  procedures 
described elsewhere (15). Alloantisera (Lewis anti-BN) were raised by subcutaneous injection of 
100 x  10  ~ BN lymphecytes in complete Freund's adjuvant followed 2 wk later by a similar dose in 
incomplete Freund's adjuvant (ICFA).  1 wk before bleeding by cardiac puncture the rats were 
boosted with 100 × l0  s BN lymphocytes in ICFA. 
For bulk treatment of cells with sera, 300  ×  106 nylon wool nonadherent splenic lymphocytes 
were  suspended  in  30  ml  of  RPMI-1640  (supplemented  with  penicillin,  streptomycin,  and 
glutamine) to which was added 3 ml of normal guinea pig serum, as a source of complement, and 
antisera (0.6 ml of Lewis anti-BN alloantibody, or 0.12 ml anti-B-cell serum or 0.15 ml anti-T-cell 
serum).  The titers of the antisera were obtained by microcytotexicity (11). The volumes of sera DONALD  BELLGRAU  AND  DARCY  B.  WILSON 
TABLE  I 
Mortality  Due to  Systemic GVH Disease  in  L/BN  Rats 
Inoculated  With TDL From L or  BN Donors 
Treatment of  F~ recipients  Mortality (dead/tetal)  after  in- 
oculation with TDL 
X-Irradia-  TDL injected  L  BN 
tion  ×  l0  s 
-  200  2/5 
100  0/5 
450 rads  100  24/24  4/4 
30-100  4/4  8/8 
20  4/4  5/5 
10  10/10  3/5 
105 
added for bulk treatment indicated above thus represent a  final concentration calculated to be 
twice that of the last dilution which kills 100% of the cells. The assays were incubated for 1 h at 
37°C with gentle agitation every 15 min. Viability was then assessed by trypan blue exclusion. 
Parallel controls using guinea pig complement or antisera alone were included. 
Results 
Susceptibility  of Irradiated Adult F1 Rats  to Systemic GVH Disease.  The 
mortality in irradiated adult F1 rats caused by systemic GVH disease is shown 
in Table I.  Various numbers of parental strain L  or BN TDL were injected 
intravenously  into  L/BN  rats  that  had  been  given  450  rads  whole  body 
irradiation 1-3 days earlier. As few as 10  ×  10  ~ L strain or 20  x  10  ~ BN strain 
TDL proved to be lethal to irradiated F1 rats within a 2-3 wk period. Animals 
with  systemic  GVH  disease  regularly  die  14-21 days  ai~r  injection  with 
parental cells. Before death, they exh~it some of the classic signs of systemic 
GVH disease (5): reddening  of ears and skin around the eyes, desquamation and 
swelling of feet, and they display a hunched posture and a wobbling gait. 
Resistance  to  Lethal  GVH  Disease  Induced  by  Inoculation  of Parental 
Lymphocytes.  L/BN F1 rats were injected i.v. with TDL from parental strain 
donors (30 × 10  ~ from L, or 50 × 10  ~  from BN) or left untreated as controls. After 
7 days they were irradiated (450 rads) and then injected i.v.  with TDL from 
either parental strain in a dose which ordinarily causes lethal GVH disease. 
The results of several experiments (Table II)  indicate that  inoculation of 
parental lymphocyte  populations into F~ rats before irradiation affords a marked 
degree of protection against lethal effects of systemic GHV disease. Further- 
more, they display none of the clinical symptoms of GVH disease indicated 
above. The resistance appears to be quite specific; L/BN F~ animals pretreated 
with L lymphecytes, for example, remain susceptible to GVH disease caused by 
lymphocytes  from BN strain donors. 
Table III shows the results of similar experiments conducted with other rat 
strain combinations. 
Adoptive  Transfer  of GVH Resistance  to  Irradiated  F~  Rats.  Whether 
resistance to GVH disease in A/B F1 hosts is mediated by cells or cell products 
of parental (A) origin or of host origin (A/B) is an important point to establish 
in understanding the underlying mechanisms of GVH resistance. To approach 106  RESISTANCE  TO  GRAFT-VERSUS-HOST  DISEASE 
TABLE II 
Specifically Induced Resistance to Lethal GVH Disease 
Mortality$ (dead/total) after inoculation with lymphocytes (- 30 
Pretreatment of  x  l0  s) from 
L/BN F~ hosts* 
L  BN  L/BN  (No cells) 
-  29/29  7/7  0/3  0/4 
L  7/56  15/15  0/6  0/6 
BN  9/9  0/7  ND  ND 
* All FI hosts received 450 rads X-irradiation; where indicated these were injected 
i.v. with lymphocytes from parental animals (30 x  l0  s Lewis or 50 × l0  s BN) 7 days 
before irradiation. 
These results are derived from several experiments in which systemic GVH disease 
was induced with 30-500  x  l0  s parental TDL. Within this range of cells there was 
no difference in the incidence of  mortality, although the onset of  mortality occurred 
somewhat later with lower dosages. 
this question directly, it was necessary to develop an adoptive transfer system 
whereby naive, irradiated A/B F1 animals could be protected against the lethal 
GVH effects of parental A strain lymphocytes  by the concommitant administra- 
tion of lymphoid cells from resistant A/B F1 rats. 
Table IV shows that 10  ×  10  ~ L TDL or 20  ×  106 BN TDL injected together 
with 50-400 x  106 splenic cells from normal L/BN donors results in lethal GVH 
disease  in  irradiated  L/BN  rats.  However,  if splenic  cells  from  F1  donors 
pretreated with L  lymphocytes are cotransferred to  irradiated F1  recipients 
along  with  GVH-inducing TDL  suspensions,  these  animals  are  specifically 
resistant to GVH disease caused by L TDL, but remain susceptible to BN TDL. 
In addition, spleen cells from L/BN donor animals that were injected with L 
TDL and then irradiated (450 rads) also conferred some degree of resistance to 
GVH disease in secondary Fi recipients. 
The resistance conferring cells in the F1 spleen cell population were fraction- 
ated  in  various  ways to  determine whether the  adoptive  transfer of GVH 
resistance is mediated by ceils of parental or of F1 host origin, and whether they 
are T  cells or B  cells.  The results  (Table  V)  show the  following:  (a) when 
separated into nylon wool adherent and nonadherent fractions, the latter were 
most effective, and (b) when nylon wool nonadherent cells were further treated 
with alloantibody specific for host alloantigens with C' or cytotoxic anti-T-cell 
serum with or without C', but not with anti-B-cell serum, the ability to transfer 
GVH resistance was abolished. These findings clearly indicate that the relevant 
cell population mediating GVH resistance consists of T cells of F1 origin, and 
provide  strong  support  for  the  possibility  that  GVH  resistance  reflects an 
immune  response  induced  in  the  primary  F1  host  against  parental  strain 
lymphocytes. 
Adoptive  Transfer of GVH Resistance  to L/BN B  Cell Rats.  The studies 
described above show that specific resistance to systemic GVH disease induced 
by immunization of F1  rats with parental  lymphocytes before irradiation is 
mediated by  a  radioresistant population of host  T  cells.  Furthermore, they 
suggest that the cellular precursors involved in the generation of GVH resist- DONALD BELLGRAU AND  DARCY B.  WILSON 
TABLE HI 
Induced GVH Resistance  in Various F1 Hybrid Rats 
Parental cells 
Recipients  injected before 
(PIIP2)  X-irradiation 
(P1) 
Mortality* after inneculation 
with parental cell 
(P1)  (P2) 
L/DA 
(L)  (DA) 
-  10/10  5/5 
30 × 10  e L  2/12  5/5 
107 
Aug/DA 
(Aug)  (DA) 
-  4/4  6/6 
50 x 10eDA  4/4  3/8 
* 50 × 106 parental TDL injected 2 days after 450 rads irradiation. 
TABLE IV 
Adoptive Transfer of Resistance  to Systemic GVH Disease 
GVH  induced  Status of  F~ 
with*  spleen donors$ 
Mortality (dead/total)  number (x I0  ~) FI spleen cells  in 
adoptive transfer 
10  25  50  100  200  400 
L TDL  Normal  10/10  12/12  6/6 
BN TDL  Normal  11/11  4/4  3/3 
L TDL  L TDL  16/61  6/41  0/6 
BN TDL  L TDL  11/11  5/5  3/3 
L TDL  Normal-x  3/3  5/5 
L TDL  L TDL-x  3/5  2/6 
4/4 
*  10-20 x 106 L or BN TDL injected into x 450 rads L/BN rats to cause GVH disease. 
* Normal, not injected; L TDL, given 30 x 10  e L TDL 10 days before cell transfer; normal-x, given 
450 rads 3 days before transfer; L TDL-x, given 30 × 106 L TDL and irradiated (450 fads) 7 days 
later, 3 days before cell transfer. 
ance are radiosensitive T lymphocytes, thus acounting for the comparative ease 
with which GVH disease can be induced in irradiated animals. 
If GVH resistance is mediated by host T  cells, it follows that adult thymecto- 
mized, lethally-irradiated, marrow reconstituted,  stable F1 B-cell rats, devoid of 
detectable T-cell functions (see Materials and Methods),  should be particularly 
vulnerable to systemic GVH disease.  This prediction was tested directly in the 
following experiment. 
Table VI shows that  (a) F1  B-cell rats, but not sham-thymectomized control 
animals,  are  very  susceptible  to  lethal  GVH  disease  without  any  further 
irradiation,  (b) this GVH susceptibility can be reversed by cotransfer of large 
numbers of syngeneic TDL, and (c) a  spleen cell population capable of transfer- 
ring GVH resistance adoptively cannot be generated in F1 B rats. 
Immunization with Alloreactive Parental T  Cells.  The induction of specific 
resistance to systemic GVH disease by administering parental strain lympho- 
cytes  before  irradiation  can  be  accounted  for by one  or  more of a  variety of 
mechanisms. One obvious possibility is the potential immunogenicity of paren- 
tal T-cell receptors, lacking in the F1 host, which are specific for host alloanti- 108  RESISTANCE  TO  GRAFT-VERSUS-HOST  DISEASE 
TABLE  V 
Adoptive Transfer of GVH Resistance to X-Irradiated L/BN F1 Rats with 
Fractionated L/BN F~ Spleen Cells 
L/BN FI spleen populations  Mortality (dead/total)  caused by L TDI~I 
(  x 10  ~)  FI spleen  cells  transferred 







NH4C1  3/3  4/4 
2/3  1/8  4/18 
Adherent  3/3 
3/3  4/7  0/9 
Nonadherent  4/4  0/3  0/14  0/23  0/4 
Normal 
L TDL 
Anti-BN alloantibody  3/3 
Anti-BN + C'  3/3 
Anti-BN alloantibody  0/6 
Anti-BN + C'  6/6 
Anti-B-cell serum  2/8 
Anti-B + C'  1/2  2/6 
Anti-T-cell serum  6/6 
Anti-T + C'  5/5 
-  C'  1/6 
* F~ donor rats were either normal or injected with 30  ×  106 L TDL 10 days before cell 
transfer. 
* All populations  passed through nylon wool were pretreated with NH4C1; Nonadherent 
cells were used for antiserum studies. 
§ No. cells transferred refers to the number of live cells before a particular treatment. Cells 
treated with antisera alone, or with C' alone were -> 95% viable; anti-BN alloantibedy + 
C' 0% viable; anti-B + C' 90% viable; anti-T + C' 10% viable. After treatment with anti- 
B + C' aliquots of this suspension were retested with anti-B + C' showing no further loss 
of viability, or with anti-T + C', showing 0% viability. 
II 10 × 106 L TDL injected into × 450 reds L/BN rats to cause GVH disease. 
gens.  Thus,  immunization of F1 animals with such parental T-cell populations 
could elicit a protective anti-receptor immunity directed to those parental T-cell 
clones responsible for GVH reactivity.  As an alternative general explanation, 
GVH  resistance  induced  with  parental  lymphoid  cells  could  reflect  a  host 
immunity  against  recessive parental  strain  alloantigens  not  expressed  in  the 
host (16,  17). 
According to the first model for GVH resistance, negatively selected parental 
T-cell populations of one strain, A, specifically depleted of immune reactivity to 
alloantigens (A-B) of a  second strain, B, should fail to induce GVH resistance in 
A/C animals.  (A, B, and C express different MHC haplotypes and also differ by 
multiple minor histocompatibility loci.) Thus, if GVH resistance reflects a  host 
immunity  against  recessive  parental  strain  alloantigens,  negatively  selected 
A_B lymphocyte populations should continue to express such antigens and they 
should be as effective as unselected A  lymphocytes in inducing GVH resistance 
in A/C F1 rats. 
To test this model directly, populations of L TDL were negatively selected to 
BN  alloantigens  by  acute  recirculation  through  irradiated  L/BN  hosts.  The 
specificity  of negative  selection  in  these  TDL  populations  (L-BN)  consisting DONALD  BELLGRAU  AND  DARCY  B.  WILSON 
TABLE  VI 




FI*  cells  used  for  adoptive  trans-  FI Recipients$  after  GVH  induced  with 
fer  parental TDL 
-  L/BN Sham  0/6 
-  L/BN B  12/12 
L/BN Normal  1.5 x  109 TDL  L/BN B  0/4 
1.0 × 109 TDL  L/BN B  1/4 
0.5 x  1IF TDL  L/BN B  4/4 
0.25 × 109 TDL  L/BN B  2/2 
IJBN B a-L  0.1  x 109 Spleen  L/BN-x  7/7 
L/BN sham a-L  0.1 × 109 Spleen  L/BN-x  1/6 
*  L/BN B  a-L, L/BN F1 B cell rat immunized with 30 x 10  e L TDL 10 days before cell 
transfer; L/BN sham a-L, sham Tx control rats similarly immunized (see Materials 
and Methods). 
$ FI recipients were L/BN Ft B cell rats or sham Tx control  animals without any 
further irradiation, or normal F~ rats irradiated with 450 rads. 
§ GVH mortality induced with 30 x 10  e L TDL in F~ B-cell rats, and 10 × 10  ~ L TDL 
in irradiated F~ recipients. 
TABLZ VII 
GVH Mortality Induced with Negatively Selected L-s.v TDL 
Populations  in L/BN and L/DA Rats 
Parental cells injected* 
Mortality (dead/total) recipients 
L/BN  L/DA 
L TDL  4/4  10/10 
L-SN TDL  0/5  4/4 
* 30 x 10  ~  TDL injected 3 days after 450 rads X-irradiation. 
mostly of T  cells, was demonstrated in MLC (data not shown),  and in systemic 
GVH reactions. These cells failed to cause GVH disease in irradiated L/BN rats 
when administered in numbers (30 ×  10  e) which proved to be lethal in irradiated 
L/DA hosts (Table VII). 
These same negatively selected T-cell populations (L-BN) were tested for their 
ability to induce GVH resistance in L/BN and L/DA rats to L TDL. The results 
(Table VIII) clearly demonstrate the failure of L-SN TDL to protect L/BN rats 
against  L  TDL despite their continued  ability to induce  GVH resistance  to L 
TDL in L/DA rats.  This finding demonstrates the requirement for alloreactive 
T  lymphocytes in  the  immunizing  parental  lymphocyte populations  and  pro- 
vides strong support for the premise that induced resistance to systemic GVH 
disease involves an immunity directed to parental T-cell receptors. 
Evidence that Induced Resistance to GVH Disease is Directed to Anti-MHC 
Receptors on Parental T Cells.  The results of the previous experiment indicate 
that the relevant antigen(s)  on the  immunizing parental lymphoid population 
used  to induce  GVH resistance  is clonally distributed  and that  most likely it 
represents  the  parental  T-cell  receptors  specific  for  host  alloantigens.  The 
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TABLE  VIII 
Systemic GVH Resistance Induced with Negatively Selected 
L-BN TDL Populations 
Immunizing paren-  Recipients 
tal cell  population* 
GVH Mortality 
caused  by  L TDL$ 
(dead/total) 
L_BN  L/BN  6/6 
L  L/BN  0/9 
L_BN  L/DA  0/4 
L  L/DA  2/8 
* 30 x  10  e normal (L) or negatively selected (L_BN)  TDL injected 7 days 
before 450 rads whole body X-irradiation. 
50 x  106 L TDL injected 3 days after irradiation to cause GVH disease. 
TABLE  IX 
GVH Resistance Tested with Parental TDL from Congenic Donors 
F, Recipients* (x 450 
rads) 
Mortality (dead/total) after GVH induced 
with:$ 
BN  L  L.B3 
L/BN Normal  7/7  7/7  4/4 
L/BN Anti-BN  0/7  7/7  i/6 
* Recipients _+ immunized with 30 ×  106 BN TDL and irradiated 7 days 
later. 
50 ×  10  + TDL injected to cause GVH disease 1 day after irradiation. 
MHC alloantigens but they also may be specific for one or more of the various 
minor alloantigens of the host. 
The following experiment (Table IX) demonstrates that GVH resistance in F, 
animals is directed at least in part against parental T-cell clones specific for 
host  MHC  alloantigens.  Three  TDL  populations  were  used  to  cause  GVH 
disease: (a) BN, potentially reactive to B1 MHC and weak alloantigens of the 
Lewis genome; (b) L, potentially reactive to B3 MHC and weak alloantigens of 
BN;  and  (c) L.B3,  potentially reactive to B1  MHC  of Lewis, and BN minor 
alloantigens. Recipient L/BN rats were immunized with BN TDL,  and tested 
for GVH resistance with these three TDL populations. As expected, they were 
resistant to GVH caused with BN TDL, but not with L TDL.  In addition, they 
were also resistant to GVH disease caused by L.B3 TDL populations, showing 
that the suppression of GVH reactivity was directed at anti-B1 T-cell clones. 
Discussion 
In previous studies  (7) we demonstrated that F1  rats injected systemically 
with lymphocytes from parental strain donors no longer display the usual local 
popliteal lymph node GVH response to footpad injections of parental T  cells 
from  the  same  strain.  This  state  of GVH  resistance  is  highly specific  for 
lymphocytes of the parental strain used to induce it, it is rapid in onset, and it 
depends on the presence of alloreactive T cells in the pretreatment inoculum. 
While  it  seemed likely that  suppressed  GVH  reactivity represented a  cell- DONALD  BELLGRAU  AND  DARCY  B.  WILSON  111 
mediated immune phenomenon of some kind,  it  was  not clear  at  the time 
whether it was mediated by coils of  donor or of host origin; nor was it possible to 
determine what the target of this immunosuppressed GVH reactivity might be. 
These questions have now been resolved in the present studies which show that 
GVH resistance represents an immune response against specific alloreactive 
parental T lymphocytes mediated by host T cells. 
Several findings directly demonstrate the importanco of host T cells beth in 
the induction of a  state of GVH resistance in adult F1 rats as well as in its 
expression. First, beth FI B-coll rats and irradiated F~ rats are quantitatively 
more vulnerable to systemic GVH disease than normal, intact F~ recipients, 
and  this  extreme  sensitivity to  GVH  disease  is  markedly reversed  by  the 
adoptive transfer of normal syngeneic TDL (Table VI). Second, a specific state 
of resistance to systemic GVH disease directed against lymphoid cells of one 
parental strain (A),  but not to the other (B), can be adoptively transferred to 
naive, syngeneic F~ recipients (A/B) from specifically immunized F1 donors (A/ 
B anti,A) (Table IV). Successful transfers of GVH resistance in this setting are 
abolished by treatment of the F1 spleen cell population with cytotoxic antisera 
specific for host alloantigens and for T-cell surfaco markers in the presence of 
complement. Why anti-T sera in the absence of complement also effectively 
abolishes adoptive transfer of GVH resistance is not totally clear, however, it 
might indicate the opsonization in vivo of T-cell subpopulations coated with 
xenogeneic rabbit immunoglobulins (18). Third, spleen cells from B-cell rats 
immunized with parental T cells are not effective in adoptive transfer of GVH 
resistance (Table VI). 
The  results  of this  study also  show that  the  immunogen responsible for 
inducing GVH  resistance maps with functional alloreactivity of parental  T 
cells, and thus it is presumed to be the receptors on parental T cells specific for 
host alloantigens. This conclusion derives from experiments designed to exclude 
the alternative possible explanation of a  host-mediated immunity directed to 
ubiquitous, nonclonally distributed, surface antigens unique to parental cells, 
for example,  recessively expressed alloantigens,  or other  surface  structures 
associated with endogenous viruses peculiar to the immunizing parental strain. 
Negatively selected parental TDL populations (L-BN), consisting predominantly 
(>  95%) of T  cells specifically depleted of alloreactivity to  BN  alloantigens 
(Table VII), fail to induce GVH resistance to parental (L) lymphocytes in L/BN 
F1 rats, but do so in L/DA F~ recipients (Table VIII). This finding indicates that 
the relevant immunogen is present on alloreactive L T lymphocytes and that it 
is most probably the T-cell receptor(s) specific for BN alloantigens of the host. 
That the immunogenic parental T-cell receptors include those specific for host 
MHC alloantigens of the Ag-B locus is demonstrated with the use of an MHC 
congenic strain.  L/BN F~ rats immunized with BN lymphocytes, a population 
containing anti-B1 receptors specific for L MHC antigens of  the Ag-B1 haplotype 
and receptors specific for L minor alloantigens as well, suppress the potential 
GVH  reactivity  of L.B3  lymphocytes (Table  IX).  This  second parental  cell 
population is presumed to have receptors specific for Ag-B1 MHC alloantigens, 
but none specific for L minor alloantigens for reasons of self toleranco. It should 
be noted that the suppression of alloreactivity of both BN and L.B3 T cells in L/ 112  RESISTANCE  TO  GRAFT-VERSUS-HOST  DISEASE 
BN rats immunized with BN lymphocytes implies a marked similarity, possibly 
shared idiotypy, of the BN anti-B1 and L anti-B1 T-cell receptors. 
Anti-idiotypic immune responses against receptors of alloreactive T cells have 
been demonstrated directly in some studies (19-22)  and inferred in others (7, 
23-25).  Some of these involve the production in F~  animals of anti-idiotypic 
antibodies specific for anti-MHC receptors present on parental T cells and for 
the variable region idiotypes on alloantibody immunoglobulin molecules (22, 
26, 27). Others involve immunization of parental strain animals with autologons 
anti-MHC blasts raised in MLC resulting in the production of killer/suppressor 
T-cell populations which inhibit specific MHC responses (28). To date, however, 
all of these anti-idiotypic responses require extensive and repeated immuniza- 
tions, most in the presence of adjuvants, and many of these studies have been 
difficult to reproduce in other laboratories. 
In this respect the present findings as well as those of our previous study are 
of particular interest. F~ animals immunized with as few as 1 ×  106 parental T 
cells  and challenged 3  days  later  show reduced local popliteal lymph node 
reactions  (11). Moreover, immunization of F, animals (which if unirradiated 
are  quite  resistant  to  systemic  GVH  disease)  as  few  as  1-3  days  prior  to 
sublethal irradiation renders them resistant to systemic GVH disease caused by 
multilethal doses of parental lymphocytes (data not shown). The basis for this 
rapid onset of radioresistant specific immunity to alloreactive parental T cells is 
the subject of continuing study; it seems to reflect an ongoing process in the 
adult F1 animal requiring the presence of an intact thymus. 
Summary 
The present studies extend our previous efforts to understand the immunolog- 
ical basis of specifically induced graft-versus-host (GVH) resistance in F1 hybrid 
rats.  Immunization of F, rats with alloreactive T-cell populations of parental 
strain origin induces a host-mediated T-cell response which is specific for anti- 
major hostocompatibility complex receptors on parental T cells. This protective 
immunity is rapid in onset and once induced, it provides a  highly effective, 
specific resistance to lethal GVH disease which is radioresistant and can be 
adoptively transferred to syngeneic recipients. 
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